• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UT GMBH TYVASO INHALATION SYSTEM; NEBULIZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UT GMBH TYVASO INHALATION SYSTEM; NEBULIZER Back to Search Results
Model Number ON-100HPA
Device Problems Device Emits Odor (1425); Battery Problem (2885)
Patient Problem No Information (3190)
Event Type  malfunction  
Event Description
A report was received through the us specialty pharmacy that a battery smelled bad.The battery was in a garage for two weeks and was smelling up the house and was noted to still smell bad.Consumer.Functional testing determined that battery pack sn (b)(4) did not meet product specifications, in that, battery pack will not hold sufficient charge to deliver minimum required amount of inhalations.The suspect odor was attributed to circuit relay overheating.Device manufacture date: 07/2010.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TYVASO INHALATION SYSTEM
Type of Device
NEBULIZER
Manufacturer (Section D)
UT GMBH
eisenfeld 6382 0
GM  63820
MDR Report Key4148304
MDR Text Key18066415
Report NumberMW5038457
Device Sequence Number1
Product Code CAF
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 06/13/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberON-100HPA
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer01/23/2012
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
TYVASO
Patient Outcome(s) Other;
-
-